Biosimilar Newsletter Archive
-
07.17.23 -- De-Risk Your mRNA Development
7/17/2023
07/17/23 Biosimilar Development Newsletter
-
07.13.23 -- Humira Biosimilars Take The U.S. Market By Storm
7/13/2023
07/13/23 Biosimilar Development Newsletter
-
07.06.23 -- FDA Issues Guidance On Manufacturing Interruptions
7/6/2023
07/06/23 Biosimilar Development Newsletter
-
06.29.23 -- Three Areas To Focus On When Building Security Of Supply
6/29/2023
06/29/23 Biosimilar Development Newsletter
-
06.29.23 -- Improving Digital Integration Between Biomanufacturers & Partners
6/29/2023
06/29/23 Biosimilar Development Newsletter
-
06.22.23 -- 5 Characteristics Of The Automated Microbiology Lab Of The Future
6/22/2023
06/22/23 Biosimilar Development Newsletter
-
06.15.23 -- Pfizer, Samsung Biologics Announce Biosimilar Manufacturing Collaboration
6/15/2023
06/15/23 Biosimilar Development Newsletter
-
06.14.23 -- A New Vial Design Capable Of Curbing Delamination And Glass Particulate Generation
6/14/2023
06/14/23 Biosimilar Development Newsletter
-
06.09.23 -- Strategies To Streamline Combination Product Development For Biosimilars
6/9/2023
06/09/23 Biosimilar Development Newsletter
-
06.08.23 -- Mark Cuban, Coherus Team Up For Broader Humira Access
6/8/2023
06/08/23 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more